Pharma News

Kite – a Gilead Sciences spin out company – has announced that the National Institute for Health and Care Excellence (NICE) has recommended additional uses for their two CAR T-cell therapies. ...

The CHMP’s positive opinion was supported by data obtained from a pivotal Phase II AReSVi-006 trial.

Eli Lilly and Co  on Thursday raised its annual revenue and profit forecasts after topping first-quarter sales estimates on demand for its closely watched diabetes drug Mounjaro, ahead of a d...

Sun Pharma says it's responding to increased pressure from the FDA following a plant inspection last August. 

The EU’s proposal for the biggest shake-up in pharma rules for decades has finally arrived, but companies say they could simply take their innovative medicines elsewhere. ...

Janssen Pharmaceuticals, a division of Johnson & Johnson, received European Commission marketing authorization for its prostate cancer drug Akeega (niraparib and abiraterone acetate), the first...

IN8bio Inc. on Tuesday said INB-400 and INB-410 received the U.S. Food and Drug Administration's orphan drug designation for a range of malignant glioma treatments, including newly diagnosed gliobl...

The results indicated TTHX1114 activated dose-dependent response in corneal oedema resolution and improved BCVA after surgery in all the patients.

AstraZeneca and Ionis Pharmaceuticals have reported that eplontersen met all co-primary endpoints and secondary endpoints in the Phase III NEURO-TTRansform trial in hereditary transthyretin-mediate...

Avidity Biosciences, Inc., a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that the U.S. Fo...

Amphastar Pharmaceuticals will buy Baqsimi from Eli Lilly and Co in a deal worth up to $1.08 billion as it aims to boost its portfolio of low blood sugar drugs, the two companies said on Monday. ...

Xortx Therapeutics has received Orphan Drug designation for its Xorlo (oxypurinol) drug to treat autosomal dominant polycystic kidney disease, the most common form of polycystic kidney disease. ...